Instituto de Investigación Sanitaria Fundación para la Investigación del Hospital Clínico de Valencia-ko ikertzaileekin lankidetzan egindako argitalpenak (10)

2021

  1. Does abdominal obesity influence immunological response to SARS-CoV-2 infection?

    Expert Review of Endocrinology and Metabolism, Vol. 16, Núm. 6, pp. 271-272

  2. Protective Effects of Statins Administration in European and North American Patients Infected with COVID-19: A Meta-Analysis

    Seminars in Thrombosis and Hemostasis, Vol. 47, Núm. 4, pp. 392-399

  3. Role of non-coding RNAs as biomarkers of deleterious cardiovascular effects in sepsis

    Progress in Cardiovascular Diseases, Vol. 68, pp. 70-77

2020

  1. Global epidemiology and future trends of heart failure

    AME Medical Journal, Vol. 5

  2. Oxidative stress and inflammation in covid-19-associated sepsis: The potential role of anti-oxidant therapy in avoiding disease progression

    Antioxidants, Vol. 9, Núm. 10, pp. 1-20

2019

  1. Long-term follow-up and treatment in a case of PAFIYAMA syndrome: urgent need for identifying related biomarkers

    AME Medical Journal, Vol. 4

  2. Routine cardiac troponin assessment after percutaneous coronary intervention: Useful or hype?

    Journal of Cardiovascular Medicine, Vol. 20, Núm. 8, pp. 495-499

2018

  1. An Overview of Doping in Sports

    Nutrition and Enhanced Sports Performance: Muscle Building, Endurance, and Strength (Elsevier), pp. 189-202

  2. “Ultra-sensitive” cardiac troponins: Requirements for effective implementatioin clinical practice

    Biochemia Medica, Vol. 28, Núm. 3

2017

  1. Challenges in the analysis of epigenetic biomarkers in clinical samples

    Clinical Chemistry and Laboratory Medicine, Vol. 55, Núm. 10, pp. 1474-1477